Grapefruit USA Executes Binding Letter Of Intent To Acquire Diagnostic Lab Corporation

Grapefruit USA, Inc. GPFT executed a binding letter of intent, entered into on June 30, 2022, by the company and Diagnostic Lab Corporation of Englewood Cliffs, New Jersey, pursuant to which the company and DLC will jointly recapitalize Grapefruit and raise $12.5 million of debt financing (including $5.5 million already committed from a qualified construction lender) to:

1. Complete construction of the company’s “Mothership” cultivation, manufacturing and distribution facility in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park, located 14 miles north of downtown Palm Springs, California.

2. Acquire all of DLC’s assets for a to-be-determined amount of cash and Grapefruit common shares.

3. Fund the company’s application for an FDA 510K approval for its patented Hourglass time release Z-POD THC/CBD/cannabinoid infused delivery cream.

4. Fund the company’s clinical study to measure the effects of the Hourglass delivery cream on the pain and other symptoms of patients who suffer from the debilitating effects of osteoarthritis.

The parties plan to retire the $12.5 million of new debt through a public equity capital raise and concurrent up-list to a U.S. or Canadian exchange, as applicable securities regulations permit.

Bradley J. Yourist, Grapefruit’s CEO and co-founder, stated, “Execution of this letter of intent between DLC and GPFT is the next step in Grapefruit’s evolution from a ‘me too’ cannabis company to a medical science-based, canna-focused biotech company that will develop and obtain regulatory approval for an ever-expanding line of proprietary cannabis products based on the company’s patented Hourglass technology.”

Yourist continued: “ Construction of the Coachillin’ ‘Mothership’ facility at the Coachillin’ Park will secure our balance sheet and provide a reliable source of reasonably priced pharma-quality cannabis flowers for raw material for THC Hourglass products and for distribution in both the U.S. and Canada, as appropriate under any given market circumstances. The 510K approval for the Hourglass technology will facilitate its rapid market acceptance throughout the United States as an approved medical device. Finally, our lab acquisition program will provide rapid revenue growth and expand the company’s cannabis industry footprint. “

The parties expect to finalize and execute the definitive agreement before the end of August 2022 and close the transaction shortly thereafter.

Photo by CRYSTALWEED cannabis on Unsplash

Related News

Health Canada Approves Grapefruit USA's Hourglass Time Release THC+CBD Delivery Cream For Sale

California Distribution Secured For Grapefruit's Cannabis Concentrate Brand 'Summit Boys'

Canna-Biotech Co. Grapefruit USA Signs Term Sheet With Dubai-Based Lender To Build GPFT 'Mothership'

Posted In: Bradley J. YouristDiagnostic Lab CorporationCannabisNewsPenny StocksMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.